Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2053814042
